Navigation Links
Watson Full Year 2011 Net Revenue Increases 29% to $4.58 Billion;
Date:2/14/2012

>2.64$
2.95Diluted earnings per share - Non-GAAP$
5.50$
5.80Diluted weighted average common shares outstanding128.9128.9(1) Includes accelerated depreciation charges. The reconciliation table is based in part on management's estimate of non-GAAP net income for the year ending December 31, 2012.  Watson expects certain known GAAP charges for 2012, as presented in the schedule above.  Other GAAP charges that may be excluded from non-GAAP net income are possible, but their amounts are dependent on numerous factors that we currently cannot ascertain with sufficient certainty or are presently unknown.  These GAAP charges are dependent upon future events and valuations that have not yet been performed.

The following table presents a reconciliation of forecasted net income for the twelve months ending December 31, 2012 to adjusted EBITDA:Table 7Watson Pharmaceuticals, Inc.Reconciliation Table - Forecasted Adjusted EBITDA(Unaudited; in millions)Forecast for Twelve MonthsEnding December 31, 2012LowHighGAAP net income

$
340$
380Plus:Interest expense

8080Interest income

(1)(1)Provision for income taxes

280315Depreciation (includes accelerated depreciation)

100100Amortization

440440EBITDA

1,2391,314Adjusted for:Global supply chain initiative

55Acquisition and licensing charges

2020Share-based compensation

3636Adjusted EBITDA

$
,300$
,375The reconciliation table is based in part on management's estimate of adjusted EBITDA for the year ending December 31, 2012.  Watson expects certain known GAAP charges for 2012, as presented in the schedule above.  Other GAAP charges that may be excluded from estimated EBITDA are possible, but their amounts are dependent on numerous factors that we currently cannot ascertain with sufficient certainty or are presently unknown.  These GAAP charges are dependent upon future events and valuations that have not yet be
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015 Mike Rowe , spokesperson and ... Good Neighbor Pharmacy,s 2015 ThoughtSpot conference and ... Las Vegas, Nev. ... Do It," and Discovery Channel,s, "Dirty Jobs," Mr. Rowe spent ... "unsung heroes" – people whose hard work, sacrifice and value ...
(Date:7/28/2015)... Inc. (NYSE: CRY ), a leading medical device ... surgery, announced today its results for the second quarter ... Pat Mackin, Chairman, President and Chief Executive Officer, said, ... growth strategy with solid progress on several of our ... transition to a direct sales model in France, advancing ...
(Date:7/28/2015)... 28, 2015 Dipexium Pharmaceuticals, Inc. (NASDAQ: ... on the development and commercialization of Locilex® (pexiganan ... data will be presented at the American Society ... Chemotherapy and International Society of Chemotherapy,s International Congress ... in San Diego, California , ...
Breaking Medicine Technology:Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 2Dipexium Pharmaceuticals' Pexiganan Demonstrates Microbiological Activity Against Pathogens Resistant to other Topical Antibiotics 3
... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... in Elderly AML) Phase 2 clinical,trial of voreloxin ... The REVEAL-1 trial is being conducted in previously ... are unlikely to,benefit from standard induction therapy. The ...
... EASTON, Mass., May 21 Pressure,BioSciences, Inc. (Nasdaq: ... the New York University (NYU) School of Medicine, ... Public Health made presentations,highlighting the advantages of the ... scientific meetings earlier this week.,There were three oral ...
Cached Medicine Technology:Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 2Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 3Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 4Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia 5Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 2Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 3Seven Presentations by Two Independent Research Groups Highlight Advantages of Pressure Cycling Technology (PCT) at Scientific Symposia in Philadelphia, Boston, and New York City 4
(Date:7/28/2015)... Littleton, MA (PRWEB) , ... July 28, 2015 ... ... fresh look, user-friendly navigation, portal to access industry practices, consumer education, resource library, ... Blog has visitors from around the globe and offers regular posts with valuable ...
(Date:7/28/2015)... ... July 28, 2015 , ... Darryl ... as volunteers celebrate the 14th year of raising money for the Darryl Worley ... Savannah for this year’s main concert Saturday, Oct. 3. , This year’s concert ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... with 1 in 68 children currently affected with the disorder. For these families, ... the road to recovery is extremely daunting. That’s where Talk About Curing Autism ...
(Date:7/28/2015)... ... July 28, 2015 , ... ADLINK Technology, ... for edge devices that enable the Internet of Things (IoT), announced its new ... processor to provide exceptional computing power and multitasking capabilities. The MLC 4-21 is ...
(Date:7/28/2015)... ... July 28, 2015 , ... OrthAlign, ... of its ORTHALIGN PLUS® system, a palm-sized, single-use navigation device for Total Hip ... combined precision with practicality in a revolutionary way for Total Knee Arthroplasty surgeries ...
Breaking Medicine News(10 mins):Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 2Health News:Worley’s 14th Tennessee River Run Will Host Wade Hayes, Lorrie Morgan, Tracy Lawrence and Others 3Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 2Health News:ADLINK Launches High Performance, Fully-Sealed Medical-Grade Panel PC 3Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 2Health News:OrthAlign, Inc. Announces U.S. Commercial Launch of ORTHALIGN PLUS®, the most complete handheld navigation device for use in Total Hip Arthroplasty Surgery 3
... HealthDay Reporter , FRIDAY, June 24 (HealthDay News) -- Autism ... engineers and computer programmers who have autistic children compared to, ... to those observations. Researchers from Cambridge University in England ... with an autism spectrum disorder in a region of the ...
... News) -- Snacking accounts for 25 percent of the calories ... of those snacking calories, a new study indicates. Since ... that averages 580 calories per day, said Richard D. Mattes, ... West Lafayette, Ind. Because many Americans don,t think about ...
... thousands of tiny worms and a homegrown invention to ... Disease. A team of researchers from the faculties ... $450,000 grant from the Collaborative Health Research Projects program, ... to search for effective new drugs to treat the ...
... , FRIDAY, June 24 (HealthDay News) -- Among U.S. drivers ... positive for drugs, a new study has found. Most commonly, ... such as cocaine and amphetamines, and each of these drugs accounted ... in the July issue of the Journal of Studies on ...
... study confirms that medications with anticholinergic activity, which include ... impairment. The research is also the first to identify ... over-the-counter and prescription sleep aids and incontinence treatments ... the impact of these medications on 13,000 men and ...
... HealthDay Reporter , THURSDAY, June 23 (HealthDay News) -- ... salad dressing appeal to many, but new evidence indicates that ... foods and that those who can,t may end up eating ... presented at the 2011 Institute of Food Technologists annual meeting ...
Cached Medicine News:Health News:More Autism Diagnoses in High-Tech Areas, Study Finds 2Health News:More Autism Diagnoses in High-Tech Areas, Study Finds 3Health News:Tiny worms head into the breach as team searches for Parkinson's treatment 2Health News:Drug Use May Play Role in 25% of Driver Deaths, Study Finds 2Health News:Common drugs linked to cognitive impairment and possibly to increased risk of death 2Health News:Common drugs linked to cognitive impairment and possibly to increased risk of death 3Health News:Poor 'Fat-Tasters' May Tend to Be Heavier 2Health News:Poor 'Fat-Tasters' May Tend to Be Heavier 3
...
... contains primers and a FAM-labeled probe that is ... 532-labeled probe to detect Flu B. In addition, ... probe for a separate sample processing control. This ... Alexa 532 and Texas Red reporter dyes such ...
...
Digital Ultrasonic Diagnostic Imaging System...
Medicine Products: